|

Perioperative Multimodal Analgesia for Supratentorial Craniotomy

RECRUITINGN/ASponsored by Beijing Tiantan Hospital
Actively Recruiting
PhaseN/A
SponsorBeijing Tiantan Hospital
Started2026-03-09
Est. completion2027-12-31
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted

Summary

This randomized clinical trial aims to evaluate the effectiveness of scalp nerve blocks and dexmedetomidine in reducing opioid use and preventing postoperative delirium in patients undergoing supratentorial brain tumor surgery. A total of 2000 patients will be randomly assigned to one of four groups, receiving either active treatments, placebos, or their combinations.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Aged from 18 to 65 years
* American Society of Anesthesiologists physical status I to III
* Scheduled to undergo elective supratentorial tumor resection

Exclusion Criteria:

* Incision-area skin infection
* A history of previous craniotomy
* Allergy to study medications
* A history of preoperative change in consciousness or cognitive function
* Inability to communicate,
* Preoperative pain in the surgical region
* Severe hepatic or renal dysfunction
* Severe bradycardia (heart rate\<40 beats/min)
* Sick sinus syndrome or second- to-third degree atrioventricular block

Conditions4

AnalgesiaCancerPostoperative PainSupratentorial Brain Tumor

Interventions1

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.